Chest Department -Faculty of Medicine
Alexandria, Egypt, 11511
NCT Number: NCT06906354
Fiberoptic Bronchoscopic Removal of Secretions and Antibiotic Injection
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Alexandria, Egypt, 11511
fiberoptic bronchoscopic injection of dexamethason and gentamicin after airway clearance
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
1- Adult subjects. 2- Male and female subjects are enrolled. 3- patients with NCFB confirmed by chest high-resolution computed tomography (HRCT) 4- patients needing antibiotic treatment at the hospital due to exacerbation 5- Patients who underwent AC by bronchoscopy at the hospital.
-
Exclusion criteria
1- Uncooperative subjects. 2- Unwilling to participate. 3- Inability to lie on the back with raised arms over the head for HRCT. 4- Presence of cystic pulmonary fibrosis; 5- Patients with active pulmonary tuberculosis; 6- Those awaiting surgery; 7- Patients who underwent interventional therapy for hemoptysis; those with allergic bronchopulmonary aspergillosis (ABPA); 8- Patients who did not undergo bronchoscopy for different reasons or combined with lung cancer.
-
Airway Clearance by Fiberoptic Bronchoscopy in Bronchiectasis Followed by Gentamicin and Dexamethason Injection
Time frame: one month
improvement in the scale of dyspnea before and after the procedure
Alexandria University
Other
The Effect of Intrabronchial Therapy With Gentamycin and Dexamethason After Bronchoscopic Airway Clearance in Exacerbation of Bronchiectasis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07608328
Bronchial Diseases, Bronchiectasis
Asyut, Egypt
View Trial DetailsNCT06625944
Bronchial Diseases, Bronchiectasis
London, United Kingdom
View Trial DetailsNCT06931002
Bronchial Diseases, Bronchiectasis
London, United Kingdom
View Trial DetailsNCT07540936
Bronchial Diseases, Bronchiectasis
Istanbul, Beykoz, Turkey (Türkiye)
View Trial Details